These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 723450)

  • 21. Characterization of sulpiride-displaceable 3H-YM-09151-2 binding sites in rat frontal cortex and the effects of subchronic treatment with haloperidol on cortical D-2 dopamine receptors.
    Kazawa T; Mikuni M; Higuchi T; Arai I; Takahashi K; Yamauchi T
    Life Sci; 1990; 47(6):531-7. PubMed ID: 2402179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D2 dopamine receptors in rat striatum are homogeneous as revealed by ligand-binding studies.
    Leonard MN; Halliday CA; Marriott AS; Strange PG
    Biochem Pharmacol; 1988 Nov; 37(22):4335-9. PubMed ID: 3196358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine antagonist binding: a significant decrease with morphine dependence in the rat striatum.
    Puri SK; Spaulding TC; Mantione CR
    Life Sci; 1978 Aug; 23(6):637-41. PubMed ID: 567730
    [No Abstract]   [Full Text] [Related]  

  • 24. Hyperprolactinemia induced by long-term domperidone treatment does not alter the sensitivity of striatal dopamine receptors.
    Scavone C; DeLucia R; Dos-Santos LF
    Braz J Med Biol Res; 1991; 24(6):591-4. PubMed ID: 1823276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnesium ions reveal nanomolar potency of dopamine at [3H]spiperone labelled D-2 receptors in rat corpus striatum.
    De Vries DJ; Beart PM
    Eur J Pharmacol; 1985 Mar; 109(3):417-9. PubMed ID: 3157589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
    Faedda G; Kula NS; Baldessarini RJ
    Biochem Pharmacol; 1989 Feb; 38(3):473-80. PubMed ID: 2563653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine D2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices.
    Pizzi M; Da Prada M; Valerio A; Memo M; Spano PF; Haefely WE
    Brain Res; 1988 Jul; 456(2):235-40. PubMed ID: 2974746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I
    Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Demonstration of dopaminergic receptors in human pituitary adenomas secreting prolactin].
    Bression D; Martres MP; Peillon F
    C R Seances Acad Sci D; 1979 Jul; 289(2):133-5. PubMed ID: 117916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current theories on the role of dopamine in the mechanism of action of neuroleptic drugs].
    Płaźnik A; Kostowski W
    Psychiatr Pol; 1984; 18(1):39-47. PubMed ID: 6146150
    [No Abstract]   [Full Text] [Related]  

  • 31. Enhancing effect of dopamine blockers on evoked acetylcholine release in rat striatal slices: a classical D-2 antagonist response?
    Boireau A; Chambry J; Dubedat P; Farges G; Carruette AM; Zundel JL; Blanchard JC
    Eur J Pharmacol; 1986 Aug; 128(1-2):93-8. PubMed ID: 2875894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeated electroconvulsive shock (ECS) enhances striatal D-1 dopamine receptor turnover in rats.
    Nowak G; Zak J
    Eur J Pharmacol; 1989 Aug; 167(2):307-8. PubMed ID: 2687010
    [No Abstract]   [Full Text] [Related]  

  • 33. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP; Wooten GF
    Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ascorbic acid, redox cycling, lipid peroxidation, and the binding of dopamine receptor antagonists.
    Heikkila RE; Manzino L
    Ann N Y Acad Sci; 1987; 498():63-76. PubMed ID: 3476003
    [No Abstract]   [Full Text] [Related]  

  • 35. Heterogeneous distribution of dopamine D2 receptors within the rat striatum as revealed by autoradiography of [3H]N-n-propylnorapomorphine binding sites.
    Dubois A; Scatton B
    Neurosci Lett; 1985 Jun; 57(1):7-12. PubMed ID: 3162114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3H-Spiroperidol binding to dopamine receptors in rat striatal membranes: influence of loxapine and its hydroxylated metabolites.
    Coupet J; Rauh CE
    Eur J Pharmacol; 1979 Apr; 55(2):215-8. PubMed ID: 456420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sodium ion modulates D2 receptor characteristics of dopamine agonist and antagonist binding sites in striatum and retina.
    Makman MH; Dvorkin B; Klein PN
    Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4212-6. PubMed ID: 6213964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [3H] 2-Amino-6,7-dihydroxy 1,2,3,4-tetrahydronapthalene (ADTN): a potential specific dopamine receptor ligand.
    Clement-Cormier Y; Abel M
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):15-25. PubMed ID: 725314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine receptor binding for agonists and antagonists in thermal exposed membranes.
    Lew JY; Goldstein M
    Eur J Pharmacol; 1979 May; 55(4):429-30. PubMed ID: 467499
    [No Abstract]   [Full Text] [Related]  

  • 40. Reversal of two manifestations of dopamine receptor supersensitivity by administration of L-dopa.
    Friedhoff AJ; Bonnet K; Tosengarten H
    Res Commun Chem Pathol Pharmacol; 1977 Mar; 16(3):411-23. PubMed ID: 847296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.